Stocks in News: WOCKHARDT, V2RAIL, BIOCON, OPTIMUS, PROCOT, MOIL, CAPITALSFBANK, DIVISLAB, IRFC, HEROMOTO, DMART, AXISCADS
AHMEDABAD, 3 JANUARY: Wockhardt: Indian Drug Regulator approves new generation oral antibiotic MiqnafR for the treatment of community-acquired bacterial Pneumonia. (Positive) V2 Retail: Standalone Revenue Up 58% at ₹591 Cr Vs ₹373.8 Cr (YoY) (Positive) NHPC: Company received Rs 250 crore as the second installment of gross payment under a mega insurance policy. (Positive) Biocon:…
